Medium-Term Management Plan 16-20 ~Open Up the Future
1. Overview of the Medium-Term Management Plan 16-20
Mitsubishi Tanabe Pharma has identified four strategic priorities to Open Up the Future in the medium-term management plan-Maximizing Pipeline Value, Strengthening IKUYAKU(Drug Fostering and Evolution) and Marketing, Accelerating U.S. Business Development, and Reforming Operational Productivity. On that basis, the Company will implement reforms to become a “company that works with a sense of speed and is the first to deliver differentiated value.”
- (1) Name and period
- Name: Medium-Term Management Plan 16-20: Open Up the Future
Period: April 2016 - March 2021 (5 years)
- (2) Key Concept
-
2. Four Strategic Priorities to Open Up the Future
(1) Maximizing Pipeline Value: Creating Differentiated Value as Rapidly as Possible
<“R&D process reforms” & “Expansion of medical and discovery technologies”>
(2) Strengthening IKUYAKU (Drug Fostering and Evolution) and Marketing: Delivering Differentiated Value to Patients
<“Maximizing product value” & “Strengthening sales promotions”>
(3) Accelerating U.S. Business Development: Build Foundation for Sustained Growth
<“Establishing operational foundation” & “Building product lineup”>
(4) Reforming Operational Productivity: Realizing a Corporate Culture with a Sense of Speed and Profit Structure
<“Cost reductions” & “Utilization of human resources”>
3. Financial Guidance
| Fiscal 2017 actual |
Fiscal 2020 objectives *2 |
Fiscal 2023 Management Figures (image for the future) |
||
|---|---|---|---|---|
| Revenue | ¥433.8 billion | ¥430.0 billion | more than ¥500.0 billion | |
| Core operating profit *1 | ¥78.5 billion | ¥60.0 billion | more than ¥100.0 billion | |
| Net income attributable to owners of the Company |
¥57.9 billion | ¥40.0 billion | - | |
| R&D investment | ¥79.0 billion | ¥85.0 billion | ¥80.0 billion | |
| Overseas sales ratio | 26% | 30% | - |
- *1a profit excluding the income and loss recorded by non-recurring items include restructuring loss and others
- *2In consideration of the progress of the medium-term management plan, the company made interim revision to the fiscal 2020 numerical objectives and future initiatives, and announced it on November 19, 2018.